Results 151 to 160 of about 36,463 (268)

Identifying established human placental markers of schizophrenia in rodents after gestational ∆9-tetrahydrocannabinol exposure†. [PDF]

Biol Reprod
Kocsis AM, Perez-Valenzuela E, Rodríguez-Ruiz M, Sarikahya MH, Dembla A, Natale DRC, Laviolette SR, Hardy DB.   +7 more
europepmc   +1 more source

Illicit Drug‐Derived Volatile Organic Compounds as Markers for Application in Noncontact Detection Technology

The Chemical Record, Volume 26, Issue 3, March 2026.
This review highlights the characteristic odor markers of illicit drugs, emphasizing volatile markers from both natural and synthetic sources, and explores the shift from canine‐based detection to emerging noncontact sensing technologies. Illicit drug use remains a global concern, requiring effective detection methods to counter evolving concealment ...
Minwoo Kim, Solpa Lee, Anmo J. Kim, Cong Wang, Yongwoo Jang   +4 more
wiley   +1 more source

Clinical outcomes from a mid-western opioid treatment program during covid-19 emergency regulations: a brief report on the effect of tetrahydrocannabinol (THC) use on take home methadone access. [PDF]

Harm Reduct J
LaCourt ET, Ibekie O, Dike CC, Jegede O.
europepmc   +1 more source

Evaluating the OMNI Database: Statistical Analysis of Time‐Shifted L1 Data Versus Direct Near‐Earth Solar Wind Observations

Journal of Geophysical Research: Space Physics, Volume 131, Issue 3, March 2026.
Abstract This study presents a comprehensive statistical comparison of solar wind measurements between the OMNI database which contains data collected at L1 that is shifted to the bow shock nose, and near‐Earth observations from MMS, Cluster, and THEMIS missions near the bow shock nose.
G. H. Blüthner, M. Volwerk, D. Schmid, R. Nakamura, M. Temmer, O. W. Roberts, F. Koller, A. Varsani   +7 more
wiley   +1 more source

Cannabis Use in Orthopaedic Surgery: Effects on Fracture Healing, Opioid Requirements, and Clinical Outcomes. [PDF]

Cureus
Luigi Martinez HE, Rivera Troia FM, Babilonia Beltran PA, Flores Carrasquillo EC, Fernandez-Sotero R, Señeriz Ortiz R.   +5 more
europepmc   +1 more source

Developmental Effects of Cannabidiol and &Dgr;9-Tetrahydrocannabinol in Zebrafish

Toxicological Sciences, 2018
Dennis R. Carty, C. Thornton, James H. Gledhill, K. Willett   +3 more
semanticscholar   +1 more source

Incidents of sudden death during restraint of agitated individuals in Sweden between 1992 and 2024

Journal of Forensic Sciences, Volume 71, Issue 2, Page 821-836, March 2026.
Abstract Restraint‐related sudden deaths in agitated individuals raise complex questions at the intersection of medicine and law. Hyperactive delirium with extreme agitation as well as positional asphyxia due to restraint have been proposed to account for these deaths. However, the exact physiological mechanisms responsible and to what extent restraint
Alexander Tyr, Erik Lindeman, Fredrik Tamsen, Ingemar Thiblin, Brita Zilg   +4 more
wiley   +1 more source

Single oral administration of dronabinol increases ocular blood flow in patients with glaucoma

Acta Ophthalmologica, Volume 104, Issue 2, Page 225-232, March 2026.
Abstract Purpose Glaucoma is a leading cause of irreversible blindness globally, primarily driven by elevated intraocular pressure (IOP). Still, some patients progress despite significant IOP lowering, potentially due to impaired ocular blood flow. This study aimed to evaluate the effects of dronabinol, a synthetic tetrahydrocannabinol derivative, on ...
Theresa Lindner, Viktoria Pai, Patrick Janku, Nikolaus Hommer, Anton Hommer, Marihan Abensperg‐Traun, Liudmyla Petric, Leopold Schmetterer, Gerhard Garhöfer, Doreen Schmidl   +9 more
wiley   +1 more source

Effect of Δ9-tetrahydrocannabinol and cannabidiol on myofascial pain modulation in patients with temporomandibular disorder: a prospective crossover study. [PDF]

Clinics (Sao Paulo)
Schinko FGB, Paranhos LR, Gonçalves de Sousa L, Phelipe de Paula Santos G, de Mello Rode S, Sergio Guimarães A, Cama Ramacciato J.   +6 more
europepmc   +1 more source

A Phase I Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Fenebrutinib and Effect on the QT/QTc Interval in Healthy Participants

Clinical and Translational Science, Volume 19, Issue 3, March 2026.
ABSTRACT Fenebrutinib is a Bruton's tyrosine kinase inhibitor under investigation for the treatment of multiple sclerosis. The goal of this study was to investigate the effect of fenebrutinib on cardiac repolarization (QT interval) as well as its safety, tolerability, and pharmacokinetics in healthy participants.
Yan Xu, Sonoko Kawakatsu, Denison Kuruvilla, John N. Ratchford, Qi Qi, Malgorzata Sierzega, Lin Pan, Jiajie Yu   +7 more
wiley   +1 more source